Access the full text.
Sign up today, get DeepDyve free for 14 days.
AA Yunis (1978)
The year in haematology
Fitchen Jh, Cline Mj (1980)
The effect of granulopoietic stress in mice with "latent" bone marrow failure.Experimental hematology, 8 6
R. Carter (1980)
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to HumansJournal of Clinical Pathology, 33
A. Morley, K. Trainor, R. Seshadri (1978)
Chronic hypoplastic marrow failure and residual injury.Blood cells, 4 1-2
CM Andrews, NW Spurling, JA Turton (1992)
Complete automated evaluation of haematological parameters using the Technicon H*1 haematology system: experimental studies with busulphan in the mouseHuman Exp Toxicol, 11
W. Jelkmann, C. Bauer (1980)
beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice.Experimental hematology, 8 6
R. Irons, D. Colagiovanni, W. Stillman (1996)
Murine thymic lymphoma is associated with a species-specific hematopoietic progenitor cell subpopulation.Toxicology, 113 1-3
A. Morley, Kevin Trainor, Judith Blake (1975)
A primary stem cell lesion in experimental chronic hypoplastic marrow failure.Blood, 45 5
CG Geary (1978)
Aplastic anaemia
N. Young (1996)
Immune pathophysiology of acquired aplastic anaemiaEuropean Journal of Haematology, 57
A. Yunis, G. Bloomberg (1964)
CHLORAMPHENICOL TOXICITY: CLINICAL FEATURES AND PATHOGENESIS.Progress in hematology, 4
F. Appelbaum, A. Fefer (1981)
The pathogenesis of aplastic anemia.Seminars in hematology, 18 4
D Yallop, CM Andrews, D Holt (1998)
Chloramphenicol is haemotoxic at high dose levels in the mouse but not in the ratHuman Exp Toxicol, 17
C. Andrews, L. Dash, T. Williams, J. Gray, J.A Turton (1997)
Long-term effects of busulphan on lymphocyte subpopulations in female B6C3F1 miceComparative Haematology International, 7
CM Andrews, NW Spurling, JA Turton (1993)
Myelotoxity in female B6C3F1 mice induced by busulphanHuman Exp Toxicol, 12
N. Josvasen, A. Bøyum (2009)
Haematopoiesis in busulphan-treated mice. A comparison between two different stem cell assays.Scandinavian journal of haematology, 11 1
L. Botnick, E. Hannon, S. Hellman (1979)
A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents.International journal of radiation oncology, biology, physics, 5 9
W. Hunstein (1965)
[Is Myleran (busulfan) a leukemogenic substance?].Schweizerische medizinische Wochenschrift, 95 43
MFW Festing (1987)
Genetic factors in toxicology: implications for toxicological screeningCRC Crit Rev Toxicol, 18
E. Robin, M. Berman, N. Bhoopalam, H. Cohen, W. Fried (1981)
Induction of lymphomas in mice by busulfan and chloramphenicol.Cancer research, 41 9 Pt 1
Haak Hl (1980)
Experimental drug-induced aplastic anaemia.Clinics in haematology, 9
(1990)
Chloramphenicol, vol. 50
A. Morley, Judith Blake (1974)
An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.Blood, 44 1
C. Andrews, N. Spurling, J. Turton (1993)
Characterisation of busulphan-induced myelotoxicity in B6C3F1 mice using flow cytometryComparative Haematology International, 3
W Hunstein (1965)
1st myleran (busulphan) eine leukämogene substanz?Schweiz Med Wochenschr, 95
L. Elson (1955)
A Comparison of the Effects of Radiation and Radiomimetic Chemicals on the BloodBritish Journal of Haematology, 1
K. Halka, J. Caro, A. Erslev (1987)
Long-term marrow cultures from mice with busulfan-induced chronic latent aplasia.The Journal of laboratory and clinical medicine, 109 6
A. Morley, J. Blake (1974)
Haemopoietic precursor cells in experimental hypoplastic marrow failure.The Australian journal of experimental biology and medical science, 52 6
DA Karnofsky (1967)
Late effects of immunosuppressive anticancer drugsFed Proc, 26
Karnofsky Da (1967)
Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs., 26
M. Festing (1987)
Genetic factors in toxicology: implications for toxicological screening.Critical reviews in toxicology, 18 1
N. Ideriha, I. Vugman, R. Falcão (1984)
Ectopic bone marrow development in experimental busulfan-induced hypoplastic anemia in miceBlut: Zeitschrift für die Gesamte Blutforschung, 48
D. Boggs, S. Boggs (1980)
The Effect of Graded, Single Doses of Busulfan on Murine Erythropoiesis 1Proceedings of the Society for Experimental Biology and Medicine, 163
R. Irons, W. Stillman (1996)
The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentiationEuropean Journal of Haematology, 57
Julian Down, Adrienne Berman, Michael Warhol, Pim Dijken, J. Ferrara, B. Yeap, S. Hellman, P. Mauch (1989)
Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.International journal of radiation oncology, biology, physics, 17 1
A. Morley, Kevin Trainor, Judith Remes (1976)
Residual Marrow Damage: Possible Explanation for Idiosyncrasy to ChloramphenicolBritish Journal of Haematology, 32
AM Miller, GK Arimura, MA Gross, AA Yunis (1978)
In vitro evidence for genetically determined variations in marrow erythroid sensitivityExp Hematol, 6
T. Pazdernik, M. Corbett (1980)
Role of chloramphenicol reduction products in aplastic anemia.Pharmacology, 20 2
K. Udupa, H. Okamura, K. Reissmann (1972)
Granulopoiesis during myleran-induced suppression of transplantable hen atopoietic stem cells.Blood, 39 3
G. Farris, J. Everitt, R. Irons, J. Popp (1993)
Carcinogenicity of inhaled benzene in CBA mice.Fundamental and applied toxicology : official journal of the Society of Toxicology, 20 4
Robert Boyd, Jaime Caro, Kathleen Halka, Allan Erslev (1986)
Granulopoiesis in long-term culture by marrow from mice with busulfan-induced chronic latent aplasia.International journal of cell cloning, 4 5
N. Bhoopalam, K. Price, H. Norgello, J. Barone-Varelas, W. Fried (1986)
Busulfan and chloramphenicol induced T cell lymphoma: cell surface characteristics and functional properties.Clinical and experimental immunology, 64 3
N Josvasen, A Boyum (1973)
Haematopoiesis in busulphan-treated miceScand J Haematol, 11
A. Miller, G. Arimura, M. Gross, A. Yunis (1978)
In vitro evidence for genetically determined variations in marrow erythroid cell sensitivity to chloramphenicol.Experimental hematology, 6 5
D. Holt, C. Andrews, J. Payne, T. Williams, J. Turton (1998)
The myelotoxicity of chloramphenicol: in vitro and in vivo studies: II: in vivo myelotoxicity in the B6C3F mouseHuman and Experimental Toxicology, 17
C. Pugsley, I. Forbes, A. Morley (1978)
Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulfan.Blood, 51 4
PC Vincent (1986)
Drug-induced aplastic anaemia and agranulocytosis: incidence and mechanismsDrugs, 31
A. Upton, F. Wolff, E. Sniffen (1961)
Leukemogenic Effect of Myleran on the Mouse ThymusProceedings of the Society for Experimental Biology and Medicine, 108
A. Hall, M. Tilby (1992)
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.Blood reviews, 6 3
L. Wathen, R. DeGowin, D. Gibson, S. Knapp (1982)
Residual injury to the hemopoietic microenvironment following sequential radiation and busulfan.International journal of radiation oncology, biology, physics, 8 8
(1988)
Toxicological evaluation of certain veterinary drug residues in food
P. McManus, L. Weiss (1984)
Busulfan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies.Blood, 64 5
Female B6C3F1 mice (12–14 weeks old) were dosed with busulphan (BU) by the intraperitoneal route at dose levels between 10 and 40 mg/kg on four occasions at 14 day intervals. Six weeks after the final dose, mice were given normal drinking water or drinking water containing chloramphenicol succinate (CAPS) at 4 mg/ml. Animals were killed at eight timepoints after the final BU dose, the last samples being taken at day 485 or 497 and a range of haematological parameters measured. During the experiment, no differences could be detected between mice receiving BU and CAPS and those receiving BU alone. Animals surviving to the end of the study displayed moderate leucopenia but no reduction in marrow cellularity nor was any effect on erythropoiesis apparent. Lymphocyte numbers were reduced in peripheral blood and bone marrow, and splenic cellularity was also reduced. Increased mortality was seen in animals which had received 40 mg BU/kg. In the first four months after BU dosing, animals killed due to ill health were pancytopenic with hypocellular marrows; deaths that occurred thereafter were due to lymphoma.
Comparative Clinical Pathology – Springer Journals
Published: Jun 4, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.